GR Infraprojects Board Approves Key Appointments and Financial Results

GR Infraprojects Limited announces the appointment of Mr. Vinod Kumar Agarwal as Chairman Emeritus effective February 6, 2026. PricewaterhouseCoopers Services LLP has been appointed as an Internal Auditor starting April 1, 2026. The board also approved the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025 and approved advancing loans/guarantees under Companies Act, 2013, subject to shareholder approval.

Leadership Transition

Mr. Vinod Kumar Agarwal has been appointed as the Chairman Emeritus of GR Infraprojects Limited. This appointment is effective from February 6, 2026, signaling a strategic shift in the company’s leadership.

Appointment of Internal Auditor

PricewaterhouseCoopers Services LLP is now the official Internal Auditor of GR Infraprojects. The firm will assume responsibilities starting April 1, 2026, bringing its expertise to enhance the company’s financial oversight.

Financial Performance: Quarter Ended December 31, 2025

The Board of Directors reviewed and approved the unaudited financial results for Q3 2026. Here’s a snapshot of the key figures:

  • Revenue from Operations: ₹2,03,949.21 lakhs
  • Total Income: ₹2,16,712.55 lakhs
  • Profit Before Tax: ₹31,493.73 lakhs
  • Profit After Tax: ₹23,215.03 lakhs

Statement of Deviation/ Variation in Use of Issue Proceeds

The company states that there is no deviation/variation in the use of issue proceeds and confirms utilization for intended purposes.

Non-Convertible Debentures (NCDs)

The company’s listed non-convertible debentures are unsecured. The amount outstanding as of December 31, 2025, is ₹21,500 lakhs. All proceeds from the issuance of non-convertible debentures have been fully utilized.

Additional Financial Details

Key financial ratios for the quarter include:

  • Debt Equity Ratio: 0.03 times
  • Debt Service Coverage Ratio: 24.47 times
  • Interest Service Coverage Ratio: 32.04 times

Source: BSE

Previous Article

Cohance Lifesciences Receives USFDA Warning Letter for Hyderabad Facility

Next Article

Hexaware Named a Top 15 Sourcing Standout by ISG